PREFER project deliverables
The page lists 15 deliverables related to the research project "PREFER".
List of Deliverables
| title and desprition | type | last update |
|---|---|---|
Report characterising the types and possible role of psychological instruments and educational tools in measuring patient preferencesMigration Programme: H2020-EU.3.1.7. - Topic(s): IMI2-2015-05-01 |
Documents, reports | 2020-04-08 |
Report characterising the criteria to be used to assess the performance of patient-preference methods, the performance of the methods on these criteria, and a gap analysisMigration Programme: H2020-EU.3.1.7. - Topic(s): IMI2-2015-05-01 |
Documents, reports | 2020-04-08 |
Final scope document for recommendationsMigration Programme: H2020-EU.3.1.7. - Topic(s): IMI2-2015-05-01 |
Documents, reports | 2020-04-08 |
Dissemination and communication planMigration Programme: H2020-EU.3.1.7. - Topic(s): IMI2-2015-05-01 |
Documents, reports | 2020-04-08 |
Report describing the candidate methodologies and assessment criteria to go forward for testing in empirical case studies and simulation studiesMigration Programme: H2020-EU.3.1.7. - Topic(s): IMI2-2015-05-01 |
Documents, reports | 2020-04-08 |
Initial data management planMigration Programme: H2020-EU.3.1.7. - Topic(s): IMI2-2015-05-01 |
Documents, reports | 2020-04-08 |
Report characterising the desires, expectations concerns, and requirements of stakeholders about methodologies for patient-preference elicitationMigration Programme: H2020-EU.3.1.7. - Topic(s): IMI2-2015-05-01 |
Documents, reports | 2020-04-08 |
Open workshop on preference elicitationMigration Programme: H2020-EU.3.1.7. - Topic(s): IMI2-2015-05-01 |
Websites, patent fillings, videos etc. | 2020-04-08 |
Report describing existing processes, conditions, and contextual factors that influence the utility and role of patientpreference studies and the rationale behind such influenceMigration Programme: H2020-EU.3.1.7. - Topic(s): IMI2-2015-05-01 |
Documents, reports | 2020-04-08 |
Report characterising the decision points throughout the medicinal product life cycle, the activities that are carried out in each step, and the types of assessments made at these points, as well as the assessment criteria used by different stakeholdersMigration Programme: H2020-EU.3.1.7. - Topic(s): IMI2-2015-05-01 |
Documents, reports | 2020-04-08 |
Website launchMigration Programme: H2020-EU.3.1.7. - Topic(s): IMI2-2015-05-01 |
Websites, patent fillings, videos etc. | 2020-04-08 |
Report describing existing qualitative and quantitative methods for measuring patient benefit-risk preferences in medical treatmentMigration Programme: H2020-EU.3.1.7. - Topic(s): IMI2-2015-05-01 |
Documents, reports | 2020-04-08 |
Report describing the requirements for patient-preference elicitation case studies to inform benefit-risk decision making for industry, Regulatory Authorities, HTA bodies, and reimbursement agencies at different decision pointsMigration Programme: H2020-EU.3.1.7. - Topic(s): IMI2-2015-05-01 |
Documents, reports | 2020-04-08 |
Defining Key Performance Indicators (KPIs)Migration Programme: H2020-EU.3.1.7. - Topic(s): IMI2-2015-05-01 |
Documents, reports | 2020-04-08 |
Final report on operational requirements for the conduct of case studiesMigration Programme: H2020-EU.3.1.7. - Topic(s): IMI2-2015-05-01 |
Documents, reports | 2020-02-17 |